Whitebox Advisors’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-466,712
Closed -$6.8M 581
2023
Q1
$6.8M Hold
466,712
0.23% 78
2022
Q4
$3.41M Hold
466,712
0.09% 116
2022
Q3
$3.23M Buy
+466,712
New +$3.48M 0.09% 117
2022
Q2
Sell
-466,712
Closed -$3.86M 995
2022
Q1
$3.86M Buy
466,712
+146,703
+46% +$1.32M 0.08% 99
2021
Q4
$3.46M Hold
320,009
0.07% 105
2021
Q3
$3.85M Buy
+320,009
New +$3.61M 0.08% 86
2021
Q2
Sell
-265,346
Closed -$3.7M 602
2021
Q1
$3.7M Hold
265,346
0.12% 77
2020
Q4
$3.76M Sell
265,346
-6,278
-2% -$81.9K 0.12% 74
2020
Q3
$3.34M Buy
+271,624
New +$3.14M 0.14% 61

Whitebox Advisors's AMYT Position: Q2 2023 in Review

Whitebox Advisors sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q2 2023, closing a stake of 466,712 shares — an estimated $6.8M sold.

Whitebox Advisors first reported a position in AMYT in Q3 2020 and held it in 9 quarters. The position peaked at $6.8M in Q1 2023. 0 funds tracked by Wall St. Rank hold AMYT as of Q2 2023.

  • Whitebox Advisors reported no remaining Amryt Pharma plc American Depositary Shares position as of Q2 2023 after selling out during the quarter.
  • Whitebox Advisors sold 466,712 Amryt Pharma plc American Depositary Shares shares in Q2 2023, an estimated $6.8M.
  • Whitebox Advisors first reported a position in Amryt Pharma plc American Depositary Shares in Q3 2020 and held it in 9 quarters.
  • Whitebox Advisors's Amryt Pharma plc American Depositary Shares position peaked at $6.8M in Q1 2023.
  • 0 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q2 2023.

Based on Whitebox Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.